Conference abstractPublished 3 Aug 2015
Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes
1Jomo Kenyatta University of Agriculture and Technology, Kenya 2Kenya Medical Research Institute ( KEMRI), Kenya 3King Fahd University of Petroleum and Minerals, Kingdom of Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We investigated the mechanisms of resistance of two antimalarial drugs Piperaquine (PQ) and Lumefantrine (LM) using the rodent parasite Plasmodium berghei as a surrogate of the human parasite, Plasmodium falciparum. We analysed the whole coding sequence of Plasmodium berghei chloroquine resistance transporter (Pbcrt) and Plasmodium berghei multidrug resistance gene-1 (Pbmdr-1) for polymorphisms. These genes are associated with quinoline resistance in Plasmodium falciparum. No polymorphic changes were detected in the coding sequences of Pbcrt and Pbmdr-1 or in the mRNA transcript levels of Pbmdr-1. However, our data demonstrated that PQ and LM resistance is achieved by multiple mechanisms that include elevated mRNA transcript levels of V-type H+ pumping pyrophosphatase (vp2), Ca2+/H+ antiporter (vcx1), gamma glutamylcysteine synthetase (ggcs) and glutathione-Stransferase (gst) genes. These mechanisms are also known to contribute to chloroquine resistance in P. falciparum and rodent malaria parasites. The increase in âÂ?Â?ggcsâÂ?Â? and âÂ?Â?gstâÂ?Â? transcript levels were accompanied by high glutathione (GSH) levels and elevated activity of glutathione-S-transferase (GST) enzyme. Taken together, these results demonstrate that Pbcrt and Pbmdr-1 are not associated with PQ and LM resistance in P. berghei ANKA, while vp2, vcx1, âÂ?Â?ggcsâÂ?Â? and âÂ?Â?gstâÂ?Â? may mediate resistance directly or modulate functional mutations in other unknown genes.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Daniel Kiboi”
- BylineArticles whose byline prints “Beatrice Irungu”
- BylineArticles whose byline prints “Jennifer Orwa”
- BylineArticles whose byline prints “Luna Kamau”
- BylineArticles whose byline prints “Lynette Isabella Ochola-Oyier”
- BylineArticles whose byline prints “Joseph Ngángá”
- BylineArticles whose byline prints “Alexis Nzila”
